Raymond James Financial Services Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-28,191
Closed -$836K 3535
2023
Q4
$836K Sell
28,191
-2,889
-9% -$57.5K ﹤0.01% 2098
2023
Q3
$493K Sell
31,080
-1,568
-5% -$26.1K ﹤0.01% 2337
2023
Q2
$616K Sell
32,648
-22,291
-41% -$263K ﹤0.01% 2222
2023
Q1
$211K Buy
54,939
+4,832
+10% +$20.6K ﹤0.01% 2875
2022
Q4
$249K Buy
50,107
+29,261
+140% +$159K ﹤0.01% 2714
2022
Q3
$100K Buy
20,846
+865
+4% +$4.56K ﹤0.01% 2996
2022
Q2
$90K Sell
19,981
-6,440
-24% -$28K ﹤0.01% 3029
2022
Q1
$126K Buy
26,421
+4,548
+21% +$25.2K ﹤0.01% 3069
2021
Q4
$162K Sell
21,873
-496
-2% -$3.08K ﹤0.01% 3046
2021
Q3
$127K Sell
22,369
-1,182
-5% -$6.83K ﹤0.01% 3081
2021
Q2
$155K Sell
23,551
-3,399
-13% -$23.7K ﹤0.01% 3069
2021
Q1
$218K Sell
26,950
-2,269
-8% -$18.5K ﹤0.01% 2854
2020
Q4
$188K Buy
29,219
+11,351
+64% +$66.2K ﹤0.01% 2737
2020
Q3
$64K Buy
17,868
+492
+3% +$1.99K ﹤0.01% 2744
2020
Q2
$80K Sell
17,376
-968
-5% -$4.12K ﹤0.01% 2669
2020
Q1
$63K Buy
18,344
+1,195
+7% +$5.22K ﹤0.01% 2292
2019
Q4
$88K Sell
17,149
-686
-4% -$2.33K ﹤0.01% 2716
2019
Q3
$43K Buy
17,835
+1,151
+7% +$3.06K ﹤0.01% 2710
2019
Q2
$36K Buy
16,684
+894
+6% +$2.11K ﹤0.01% 2762
2019
Q1
$43K Buy
15,790
+221
+1% +$957 ﹤0.01% 2713
2018
Q4
$75K Sell
15,569
-1,612
-9% -$9.78K ﹤0.01% 2431
2018
Q3
$163K Buy
17,181
+1,268
+8% +$12.2K ﹤0.01% 2585
2018
Q2
$155K Sell
15,913
-20,153
-56% -$212K ﹤0.01% 2542
2018
Q1
$379K Buy
36,066
+23,982
+198% +$237K ﹤0.01% 1900
2017
Q4
$77K Sell
12,084
-10,564
-47% -$65.2K ﹤0.01% 2404
2017
Q3
$173K Buy
22,648
+4,942
+28% +$32.8K ﹤0.01% 2317
2017
Q2
$126K Buy
+17,706
New +$81K ﹤0.01% 2317

Other funds holding IMGN

Raymond James Financial Services Advisors's IMGN Position: Q1 2024 in Review

Raymond James Financial Services Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 28,191 shares — an estimated $836K sold.

Raymond James Financial Services Advisors first reported a position in IMGN in Q2 2017 and held it in 27 quarters. The position peaked at $836K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Raymond James Financial Services Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 28,191 Immunogen Inc shares in Q1 2024, an estimated $836K.
  • Raymond James Financial Services Advisors first reported a position in Immunogen Inc in Q2 2017 and held it in 27 quarters.
  • Raymond James Financial Services Advisors's Immunogen Inc position peaked at $836K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.